The effect of N-acetyl cysteine on biofilm layers in an experimental model of chronic otitis media| ACTA Otorhinolaryngologica Italica

Abstract

Objectıve. The aim of this study was to investigate the efficacy of N-acetylcysteine (NAC) on biofilm layers and on the course of disease in chronic otitis media. Methods. Twenty-five rats that were induced with chronic otitis media (COM) were separated into three groups. In Group 1 (N = 18), 0.2% ciprofloxacin + 0.1% dexamethasone sodium phosphate + 0.5 mg/ml NAC solution was locally injected to the right ear of the rats; in Group 2, (N=18) 0.2% ciprofloxacin + 0.1% dexamethasone sodium phosphate was locally injected to the left ear of the rats. No treatment was applied to either ear of rats in Group 3 (N = 5). Histopathological and scanning electron microscope (SEM) evaluations were performed in all groups. Results. SEM revealed biofilm formation in all COM induced groups. No significant difference was seen between groups 1 and 2 in terms of suppuration levels, fibrosis, inner ear involvement, infection staging and biofilm formation (p > 0.05). Conclusıons. In this study, while histopathological and SEM evaluation revealed no effect of 0.5 mg/ml NAC on the biofilm layer in COM-induced rats, further studies with NAC at different concentrations are still needed on different types of experimental animals.

Introduction

Biofilm is a community of micrororganisms residing in a gelatinous layer with polymeric structures and its production starts by attaching to a surface ¹. Biofilm formation may take place in lifeless surfaces in vivo or in vitro. The microorganisms in biofilms are more resistant to antimicrobial agents than planktonic cells, as they have barriers impeding contact with antimicrobial agents and decreasing sensitivity ². Biofilm has also the characteristic of protecting the organism from osmotic stress, phage debris, toxic compounds and antibiotics.

Various bacterial proteins (biofilm) are produced by bacteria in chronic otitis media (COM), which increase the adhesion and penetration of them into middle ear mucosa ³. It is considered that in resistant COM, otorrhoea is possibly derived from biofilm layer ³. In cases of COM in which otorrhoea and inflammation cannot be relieved in spite of medical treatment, surgical intervention is used as an alternative treatment which aim to destroy the damaged osteitic tissue.

N-acetyl cysteine (NAC) is a precursor of glutathione and produces neuroprotection by preventing oxidative damage ^4,5. In addition to its primary use, it is also utilised in chronic bronchitis, cancer, paracetamol intoxication and aspergilloma ^6-8. NAC exerts an eradicating effect on biofilm layer produced by various bacteria ^9-12. The effect of NAC, on COM associated biofilm layer produced by primary pathogen P. aeruginosa, has been demonstrated ¹². Although the effect of NAC on biofilm layer was demonstated in infections produced by P. aeruginosa in respiratory and renal systems, its effect in COM treatment is controversial.

The aim of the present study was to investigate the effect of NAC on biofilm layer formation in COM produced in a rat model. We also investigated the role of NAC in preventing the involvement of the inner ear in COM.

Materials and methods

The present study was carried out with 30 healthy male Wistar albino rats at a weight of 180-220 gm with the approval of ethics committee of Ankara Training and Investigation Hospital (13 May 2014, No. 0018). The principles of Helsinki declaration for laboratory animals were applied. All animals were followed and cared in accordance with a protocol approved by institutional animal care group that was compliant with experimental ethical principles and animal protection laws in Turkey. Animals were isolated in standard cages throughout the experimental period and were given food and water ad libitum.

Surgical technique

The surgical procedure was carried out by the same surgeon in all rats under general anaesthesia using ketamine hydrochloride (90 mg/kg) and xylazine hydrocloride (10 mg/kg).

After otoscopic examination and otoacoustic emission tests were performed, 30 rats with normal findings were included in the present study. As in previous studies with chronic otitis model ^3,13,14, tympanic membranes of 25 rats (TM) were perforated with a proportion of 75% and 10⁶ colony P. aeruginosa strains (strain - ATCC -27853) were inoculated into the middle ear via the perforation. The same inoculation procedure was repeated one week later. Subsequently, microscopic examination was carried out twice weekly for three weeks and rats were followed up without treatment. Three weeks after the last inoculation, rats were examined under sterile conditions and external ear cultures were obtained. Otomicroscopic examination of all rats revealed COM and purulent discharge in the outer ear canal. The cultures demonstrated the presence of P. aeruginosa infection in all rats. Meanwhile, 2 rats were lost due to malnutrition. Treatments were then started; to right ears of 18 rats, (Group 1) 0.2% ciprofloxacin + 0.1% dexamethasone sodium phosphate + 0.5 mg/ml NAC and to left ears 0.2% ciprofloxacin + 0.1% dexamethasone sodium phosphate was administered (Group 2). These medical treatments were administered for 4 weeks twice a day locally by injection in the external auditory canal. In Group 3, 10 ears of 5 rats were not administered any medical treatment after inoculation. In Group 4, 10 ears of 5 rats were investigated as a control group without undergoing any procedure. Animals were decapitated after deep anaesthesia with the same protocol.

Histomorphological evaluation

After temporal bones were removed, they were fixed in 10% formalin and after decalcification paraffin blocks were prepared. 4 μm sections from paraffin blocks were stained with haematoxylin-eosin, PAS and masson trichrome stains. In the sections examined with light microscope, lesions produced by infection in external ear, middle ear, inner ear and the presence of mast cells and suppuration to determine improvement levels and development of fibrosis. As the variation in quality and quantity of lesions made it difficult to obtain repeatable objective data, fibrosis and suppuration, which are more suitable for quantitative evaluations, were evaluated semiquantitatively (-, +, ++, +++). Inner ear involvement was shown as present or absent (+, -).

In addition, stage/level of infection was evaluated histomorphologically; lesions produced by varying combinations of different histomorphological findings were classifed into acute suppurative (suppuration/fibrosis: ++ or +++/- or +) (Fig. 1) or chronic suppurative (suppuration/fibrosis: ++ or +++/++ or +++) depending on the severity and proportion of suppuration and fibrosis.

Ears in which suppuration/fibrosis were (+/+), (+/-) or (-/+), were classified as healed/improved (Fig. 2), because none of the ears undergoing treatment procedures were completely healed (suppuration/fibrosis: -/-).

Scanning electron microscopic (SEM) evaluation

Fresh specimens obtained from 5 ears of each group were fixed in 2.5% glutaraldehyde for 24 hours, irrigated in phosphate buffer (pH 7.4), fixed with 1% ozmium tetroxide in phosphate buffer (pH 7.4) and dehydrated in increasing alcohol concentrations. After dehydration, specimens were dried and mounted on metal frames with double sided adhesive tape. Subsequently, Bio-Rad (Hercules, CA) gold thick layer 150-A ° k were sprayed to specimens. SEM images were obtained with JEOL SEM ASID-10 (Tokyo, Japan) electron miscrosope at 500X-3000X magnification range.

The presence of biofilm was determined using SEM morphological findings such as three dimensional structure, variability in the size of microorganisms embedded in polysaccaride matrix and residue of multiple layers of tissue and microorganisms. 3 x 3 mm specimens sampled from middle ear mucosa were examined. With this investigation, the presence of biofilm was evaluated and in biofilm positive specimens, similar to other studies in the literature ¹⁵, and the presence of biofilm in less than 25% of all visualised surface areas was classified as (+) between 25-50% as (++) and over 50% as (+++) SEM analysis.

Statistical evaluation

Descriptive statistics were expressed with the number and percentage of cases both for nominal and ordinal variables. Nominal data were analysed with Fisher’s exact test, while ordinal data were analysed with Mann Whitney U test. Data analysis was performed using IBM SPSS version 17.0 software (IBM Corporation, Armonk, NY, USA). A p < 0.05 was considered significant for all results.

Results

In all rats with experimental COM, cultures obtained three weeks after the last inoculation revealed the P. aeruginosa infection.

Histomorphological findings

Except for the control group, which did not undergo any procedure, in all ears and temporal bones varying degrees of supurative or chronic inflammation, granulation tissue, vascularisation, fibrous tissue development and partial appearance of cholesteatoma were detected. Mast cell involvement was observed in eustachian tubes and inner ears and for the most part ossicles and tympanic membrane were completely destroyed and were surrounded by suppuration and fibrosis, accompanied by inner ear involvement. Inner ear structures; cranial nerve VIII, spinal ganglions, cochlear and vestibulare bones were partially or completely destroyed and replaced b fibrous repair tissue filling the vestibulare and tympanic ducts.

It was observed that the inner ear was completely destroyed in a few ears in which suppuration disappeared and fibrosis was very mild. It was also found that inner ear involvement was more marked in groups that did not undergo treatment (Group 3) compared to the groups that underwent treatment (Group 1, Group 2) (Fig. 1). In the evaluation of osteoblastic and osteoclastic activities, no difference was found between Groups 1 and 2 (Fig. 2).

There was no significant difference between NAC+treatment group and only treatment group with respect to severity of suppuration and fibrosis, inner ear involvement or stage of infection (p > 0.05) (Tab. I). In group 3, no statistical comparison was performed with groups 1 and 2 since extensive suppuration, fibrosis, and inner ear involvement was detected in all ears.

In the control group, which did not undergo any procedure, suppuration, fibrosis and inner ear involvement were not observed.

SEM findings

In SEM imaging, biofilm formation was established in all groups. There was no significant difference between Groups 1 and 2 in terms of biofilm formation (p > 0.05) (Tab. II).

In the evaluation of SEM findings in Group 3, widespread biofilm areas were observed on the middle ear mucosa. As there was no treatment, together with polymorphonuclear leukocytes, many free bacteria, bacteria debris and ECM appearance were also observed (Fig. 3).

In SEM findings of Group 1 rats, widespread biofilm was observed along with polymorphonuclear leukocytes.

SEM findings were similar in Group 2 to those in Group 1. Widespread biofilm formation was observed along with blood components (Fig. 4).

In control group without chronic otitis (Group 4), the normal middle ear mucosa was observed without any biofilm formation (Fig. 5).

Discussion

To our knowledge, the present study is the first attempting to experimentally demonstrate the effect of NAC on biofilm formation in the middle ear and mastoid cells in COM, in terms of histopathological and SEM findings. In refractory COM, in spite of medical treatment to which primary pathogen, P. aeruginosa, is sensitive, otorrhoea and inflammation cannot be improved. NAC also exerts an eradicating effect on biofilm layers produced by various bacteria in addition to its other benefits ^9-12,16,17. The effect of NAC on primary pathogen of COM, i.e. P. aeruginosa, has been demonstrated in many in vivo and in vitro studies ^12,16,17. For this purpose, the efficacy of NAC has been investigated at different concentrations. In addition to other routes, NAC may also be administered locally. In the study by Özcan et al. ¹⁸, in which the effect of NAC in myringosclerosis in rats was investigated, 0.6 mg and 1.2 mg topical NAC was used, and it was demonstrated that it prevents the development of myringosclerosis. In the study by El-Feky et al. ¹⁶, aiming to determine the effect of the addition of NAC to ciprofloxacin treatment for biofilms on the surface of uretheral stents, 2-4 mg/ml NAC was used, and it was determined that the development of mature biofilms declined. Zhao et al. ¹² added NAC at 0.5 mg /ml and 1 mg /ml to ciprofloxacin treatment and found that NAC decreased biofilm layer produced by P. aeruginosa and production of extrapolysaccharides. However, in that study, its effect on P. aeruginosa was investigated in patients with respiratory tract infections. Similar to this study, we used NAC at 0.5 mg/ml for eradication of biofilms. Herein, we found no significant difference between groups 1 and groups 2 with regard to severity of suppuration and fibrosis, involvement of inner ear, stage of infection or SEM findings (p > 0.05) (Figs. 1, 2). It may be thought that this is due to differences in experimental animals used, variations in dose, the infectious process in which NAC was used and different organs. In previous studies, NAC was used in vivo and in vitro in pseudomonal infections, and not in treatment of COM, which may also explain the discrepant results.

It has been demonstrated in various studies that NAC enhances osteoblastic activity and bone regeneration ¹⁹. However, in the present study, in COM model, no difference was found between Group 1 and 2 in terms of osteoblastic and osteoclastic activity (Fig. 2).

There are few studies in the literature on the effect of NAC on COM treatment. In the only study carried out by Choe et al. ²⁰, it was established that NAC with ciprofloxacin was effective in the treatment of refractory COM. Nevertheless, their study was performed with a small number of patients with no histopathological and SEM evaluation, and their conclusion was based upon solely clinical evaluation.

Severe and destructive lesions developing in all of the ears undergoing experimental treatment procedures made it difficult to evaluate the severity of histomorphological findings quantitatively, and hence to determine the grade of findings of infection and recovery. We hope that the present study will be a pioneer model that can guide future studies with biofilms and resistant infections. In future studies, lower microorganism concentrations can be used in conjunction with higher dosages of NAC. This method may better reveal the efficacy of NAC in the process of biofilm formation in COM.

Conclusions

Although there are many studies demonstrating the effect of NAC on biofilms, very few of them examined its efficacy in COM. In our study, we found no additional effect of topical NAC to the treatment of COM evaluated histopathologically and with SEM in the rat model. We suggest that further studies are required using different concentrations of NAC with different experimental animals in order to reach more definitive conclusions.

Figures and tables

Figure 1.Group1 rats, acute suppurative inflammation in middle ear (ME); there is no involvement in inner ear (İE), routine histological characteristics (suppuration +++, fibrosis-).

Figure 2.Group 1, residual necrotic lamellous bone (LB) fragments due to destruction in middle ear (ME) bone wall, caused by infection at the recovery process. Overlying new woven bone (WB) tissue and thin fibrous wall are seen on the surface of degenerated epithelium. Suppuration continues in the lümen (suppuration +, fibrosis +).

Figure 3.Group 1 rats, SEM appearance of biofilm layer.

Figure 4.SEM appearance of biofilm layer in Group 2 rats.

Figure 5.Control group SEM findings.

References

1. Leone S, Molinaro A, Alfieri F. The biofilm matrix of Pseudomonas sp. OX1 grown on phenol is mainly constituted by alginate oligosaccharides. Carbohydr Res. 2006; 341:2456-61. DOI
2. O’Toole GA, Kaplan HB. Biofilm formation as microbial development. Ann Rev Microbiol. 2000; 54:49-79. DOI
3. Dohar JE, Hebda PA, Veeh R. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media. Laryngoscope. 2005; 115:1469-72. DOI
4. Dodd S, Dean O, Copolov DL. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008; 8:1955-62. DOI
5. Berk M, Copolov DL, Dean O. N-acetyl cysteine for depressive symptoms in bipolar disorder a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008; 64:468-75. DOI
6. Riise GC, Qvarfordt I, Larsson S. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro. Respiration. 2000; 67:552-8. DOI
7. Stey C, Steurer J, Bachmann S. The effect of oral N-acetylcysteine in chronic bronchitis: aquantitative systematic review. Eur Respir J. 2000; 16:253-62. DOI
8. Kauffman CA. Quandary about treatment of aspergillomas persists. Lancet. 1996; 347:1640. DOI
9. Perez-Giraldo C, Rodriguez-Benito A, Moran FJ. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother. 1997; 39:643-6. DOI
10. Marchese A, Bozzolasco M, Gualco L. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents. 2003; 22:95-100. DOI
11. Schwandt LQ, Van Weissenbruch R, Stokroos I. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 2004; 124:726-31. DOI
12. Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010; 10:140. DOI
13. Dohar JE, Alper CM, Rose EA. Treatment of chronic suppurative otitis media with topical ciprofloxacin. Ann Otol Rhinol Laryngol. 1998; 107(10 Pt 1):865-71. DOI
14. Alper CM, Dohar JE, Gulhan M. Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone. Arch Otolaryngol Head Neck Surg. 2000; 126:165-73. DOI
15. Saylam G, Tatar EC, Tatar I. Association of adenoid surface biofilm formation and chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg. 2010; 136:550-5. DOI
16. El-Feky MA, El-Rehewy MS, Hassan MA. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol. 2009; 58:261-7.
17. Onger ME, Gocer H, Emir D. N-acetylcysteine eradicates Pseudomonas aeruginosa biofilms in bone cement. Scanning. 2016; 38:766-70. DOI
18. Ozcan C, Görür K, Cinel L. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol. 2002; 63:179-84. DOI
19. Yamada M, Tsukimura N, Ikeda T. N-acetyl cysteine as an osteogenesis-enhancing molecule for bone regeneration. Biomaterials. 2013; 34:6147-56. DOI
20. Choe WT, Murray MT, Stidham KR. N-acetylcysteine as an adjunct for refractory ear infections. Otol Neurotol. 2007; 28:1022-5.